TABLE 4.
Scale/Sub‐score | D‐12‐C total | D‐12‐C physical | D‐12‐C affective |
---|---|---|---|
6MWD | −0.17* | −0.22** | −0.02 |
MRC Dyspnoea Scale | 0.22** | 0.25** | 0.11 |
BODE index | 0.22** | 0.25** | 0.07 |
SGRQ total | 0.59** | 0.57** | 0.44** |
SGRQ symptoms | 0.26** | 0.28** | 0.17 |
SGRQ activity | 0.35** | 0.38** | 0.16 |
SGRQ impact | 0.29** | 0.26** | 0.22* |
SF‐36 total | −0.31** | −0.28** | −0.27** |
SF‐36 mental heath | −0.34** | −0.28** | −0.36** |
SF‐36 physical health | −0.24** | −0.22* | −0.168 |
CAT | 0.56** | 0.56** | 0.41** |
HADS total | 0.46** | 0.41** | 0.51** |
HADS anxiety | 0.45** | 0.38** | 0.51** |
HADS depression | 0.41** | 0.37** | 0.44** |
Abbreviations: 6MWD, Six‐Minute Walking Distance; BODE Index, Body‐Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity (BODE) Index; CAT, COPD Assessment Test; D‐12‐C, Chinese version of Dyspnoea‐12; HADS, Hospital Anxiety and Depression Scale; MRC Dyspnoea Scale, Medical Research Council Dysnoea Scale; SF‐36, 36‐Item Short Form Health Survey; SGRQ, Saint George Respiratory Questionnaire.
Correlation is significant at the 0.05 level (2‐tailed).
Correlation is significant at the 0.01 level (2‐tailed).